Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


GREY:LBLTF - Post by User

Comment by Nomoreshells4meon Jul 17, 2020 10:20am
100 Views
Post# 31280789

RE:RE:RE:RE:RE:Crickets on my end

RE:RE:RE:RE:RE:Crickets on my end
As I was pointing out to Chad. It's great to hear that your not a one trick pony. Amnioboost could probably also target Chrohns disease, rheumatoid arthritis and nice to hear it's being looked at for psoriasis. My simple point is that many people bought on the COVID-19 news. God forbid some people aren't looking to marry this stock. They just want to take the pop from the covid announcement and move along. All I wanted was an explanation as to why they haven't been able to complete a 10 patient study in 4 months in a state where cases have gone from 50 to 1,000 in june. No firm answer on that though. So I wait.
<< Previous
Bullboard Posts
Next >>